Avenue Therapeutics terminates AJ201 license; gets $2M cash, up to $24M milestones, 1.75% royalty

AVENUE THERAPEUTICS, INC.

License terminated; all AJ201 rights and assets transferred back to AnnJi; mutual releases and dismissal of disputes.
Avenue to receive $2M total within 90 days: $1M due in 30 days, $1M due in 90 days.
Potential future payments: up to $5M development milestones, up to $17M commercial milestones, 1.75% royalty on net sales.
Avenue repurchases 14,777 shares from AnnJi for $1.00 aggregate and pays $0.2M for AnnJi legal expenses.
48-month non-compete for competing products in US, Canada, EU, UK, and Israel after termination.

item 1.01 item 1.02 item 2.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-25-042570
form_type: 8-K
ticker: ATXI
cik: 0001644963
company_name: AVENUE THERAPEUTICS, INC.
filed_at: 2025-04-30T23:59:59+00:00
discovered_at: 2026-05-14T18:02:49.178166+00:00
generated_at: 2026-05-23T02:24:09.214587+00:00
sec_items: ["1.01", "1.02", "2.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-25-042570
json_url: https://secwatch.observer/filing/0001104659-25-042570.json
markdown_url: https://secwatch.observer/filing/0001104659-25-042570.md
text_url: https://secwatch.observer/filing/0001104659-25-042570.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465925042570/0001104659-25-042570-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1644963/000110465925042570/tm2513615d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-25-042570

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.